Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
Hoshino et al., engineer a human virus receptor, hACE2, and demonstrate its potential for overcoming SARS-CoV-2 mutations that otherwise hinder therapeutic interventions. Overall, the data provide insights in to the therapeutic potential of engineered receptors.
Enregistré dans:
Auteurs principaux: | Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, Nariko Ikemura, Emiko Mihara, Yuhei Kirita, Eriko Ohgitani, Osam Mazda, Daisuke Motooka, Shota Nakamura, Yusuke Sakai, Yumi Itoh, Fuminori Sugihara, Yoshiharu Matsuura, Satoaki Matoba, Toru Okamoto, Junichi Takagi, Atsushi Hoshino |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6dacf0dd324f4db5afbaae20298e4ac1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Silicon nitride: a potent solid-state bioceramic inactivator of ssRNA viruses
par: Giuseppe Pezzotti, et autres
Publié: (2021) -
Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins
par: Emiko Mihara, et autres
Publié: (2021) -
Nonlinear model predictive control for hexacopter with failed rotors based on quaternions —simulations and hardware experiments—
par: Yusuke AOKI, et autres
Publié: (2021) -
<italic toggle="yes">Bordetella</italic> Dermonecrotic Toxin Is a Neurotropic Virulence Factor That Uses Ca<sub>V</sub>3.1 as the Cell Surface Receptor
par: Shihono Teruya, et autres
Publié: (2020) -
Prediction of well-being and insight into work-life integration among physicians using machine learning approach.
par: Masahiro Nishi, et autres
Publié: (2021)